Predict your next investment

Toronto Innovation Acceleration Partners company logo
Venture Capital
BUSINESS PRODUCTS & SERVICES | Consulting & Outsourcing / Management & Strategy Consulting
tiap.ca

See what CB Insights has to offer

Investments

25

Funds

4

Partners & Customers

10

About Toronto Innovation Acceleration Partners

Toronto Innovation Acceleration Partners (TIAP) specializes in venture building of early-stage health science technologies emerging from our members. Toronto Innovation Acceleration Partners (TIAP) is a member-driven not-for-profit organization which was created in 2008 (at that time under the name "MaRS Innovation") by 13 of Toronto's top universities, institutions and research institutes, plus the MaRS Discovery District as host organization. Its mandate is to bring the members' most promising research breakthroughs to market. In addition to member support, early funding came from the Federal Government through the Centres of Excellence for Commercialization and Research program.

Toronto Innovation Acceleration Partners Headquarter Location

661 University Avenue Suite 465

Toronto, Ontario, M5G 1M1,

Canada

647-260-7869

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Toronto Innovation Acceleration Partners Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Toronto Innovation Acceleration Partners Rank

Latest Toronto Innovation Acceleration Partners News

UTEST 2021 APPLICATIONS OPEN!

Nov 23, 2021

The UTEST Program provides support to University of Toronto entrepreneurs to create research based companies. In partnership with Toronto Innovation Acceleration Partners (TIAP) and with the financial support of the Connaught Fund, it provides companies with investment capital, mentoring, business strategy and incubation space at the University of Toronto St. George Campus. We wish to acknowledge this land on which the University of Toronto operates. For thousands of years it has been the traditional land of the Huron-Wendat, the Seneca, and the Mississaugas of the Credit. Today, this meeting place is still the home to many Indigenous people from across Turtle Island and we are grateful to have the opportunity to work on this land. Subscribe to

Toronto Innovation Acceleration Partners Investments

25 Investments

Toronto Innovation Acceleration Partners has made 25 investments. Their latest investment was in MedMe Health as part of their Seed VC - II on March 3, 2022.

CBI Logo

Toronto Innovation Acceleration Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/17/2022

Seed VC - II

MedMe Health

$2.7M

Yes

4

9/21/2021

Seed VC

PhenoTips

$1.95M

Yes

GreenSky Capital, Thin Air Labs, Undisclosed Angel Investors, and Yorkville Partners

9

2/8/2018

Convertible Note

Zucara Therapeutics

No

1

12/21/2017

Seed VC

Subscribe to see more

Subscribe to see more

10

3/20/2017

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/17/2022

9/21/2021

2/8/2018

12/21/2017

3/20/2017

Round

Seed VC - II

Seed VC

Convertible Note

Seed VC

Series A

Company

MedMe Health

PhenoTips

Zucara Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$2.7M

$1.95M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

GreenSky Capital, Thin Air Labs, Undisclosed Angel Investors, and Yorkville Partners

Sources

4

9

1

10

10

Toronto Innovation Acceleration Partners Fund History

4 Fund Histories

Toronto Innovation Acceleration Partners has 4 funds, including MaRS Innovation - Pfizer Translational Research Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

4/9/2018

MaRS Innovation - Pfizer Translational Research Fund

$0.63M

1

12/12/2014

MaRS Impact Venture Fund

$99M

10

3/26/2012

MaRS Cleantech Fund

$99M

10

5/31/2011

GSK-MaRS Innovation Fund

10

Closing Date

4/9/2018

12/12/2014

3/26/2012

5/31/2011

Fund

MaRS Innovation - Pfizer Translational Research Fund

MaRS Impact Venture Fund

MaRS Cleantech Fund

GSK-MaRS Innovation Fund

Fund Type

Status

Amount

$0.63M

$99M

$99M

Sources

1

10

10

10

Toronto Innovation Acceleration Partners Partners & Customers

10 Partners and customers

Toronto Innovation Acceleration Partners has 10 strategic partners and customers. Toronto Innovation Acceleration Partners recently partnered with Amgen on September 9, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

9/12/2019

Partner

United States

TIAP TIAP Announces Strategic Partnership with Amgen - TIAP

`` Amgen is enthusiastic about this strategic partnership with TIAP , '' added Francesco Di Marco , Vice President and General Manager of Amgen .

2

6/19/2018

Partner

Germany

Evotec and MaRS Innovation establish strategic partnership to launch Fibrocor Therapeutics - Evotec

Evotec and MaRS Innovation establish strategic partnership to launch Fibrocor Therapeutics LP .

1

4/9/2018

Client

United States

$800,000 MaRS Innovation–Pfizer Translational Research Fund

MaRS Innovation is thrilled to continue our long-standing collaboration with Pfizer Inc. ; a partnership with a focus on translating the highly qualified research coming from our 15 member institutions .

1

12/21/2017

Partner

United States

Subscribe to see more

Subscribe to see more

10

11/28/2017

Partner

Canada

Subscribe to see more

Subscribe to see more

10

Date

9/12/2019

6/19/2018

4/9/2018

12/21/2017

11/28/2017

Type

Partner

Partner

Client

Partner

Partner

Business Partner

Country

United States

Germany

United States

United States

Canada

News Snippet

TIAP TIAP Announces Strategic Partnership with Amgen - TIAP

`` Amgen is enthusiastic about this strategic partnership with TIAP , '' added Francesco Di Marco , Vice President and General Manager of Amgen .

Evotec and MaRS Innovation establish strategic partnership to launch Fibrocor Therapeutics - Evotec

Evotec and MaRS Innovation establish strategic partnership to launch Fibrocor Therapeutics LP .

$800,000 MaRS Innovation–Pfizer Translational Research Fund

MaRS Innovation is thrilled to continue our long-standing collaboration with Pfizer Inc. ; a partnership with a focus on translating the highly qualified research coming from our 15 member institutions .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

1

1

10

10

Toronto Innovation Acceleration Partners Team

2 Team Members

Toronto Innovation Acceleration Partners has 2 team members, including current Chief Executive Officer, President, Parimal Nathwani.

Name

Work History

Title

Status

Parimal Nathwani

Chief Executive Officer, President

Current

Raphael Hofstein

Chief Executive Officer, President

Former

Name

Parimal Nathwani

Raphael Hofstein

Work History

Title

Chief Executive Officer, President

Chief Executive Officer, President

Status

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.